DEVELOPMENT OF A REGULATORY POST-MARKETING STUDIES DATABASE

被引：0

|

作者：

Caron, M. ^{[1
]}

Mouchet, J. ^{[1
]}

Emery, M. P.

Longin, J. ^{[1
,2
]}

Maier, W. C. ^{[3
]}

机构：

[1] MAPI Res Trust, Lyon, France

[2] MAPI, Lyon, France

[3] MAPI EPI, Lyon, France

来源：

VALUE IN HEALTH | 2009年 / 12卷 / 03期

关键词：

D O I：

10.1016/S1098-3015(10)73180-6

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

收藏

页码：A24 / A24

页数：1

相关论文

共 50 条

[41] POST-MARKETING EVALUATION OF DRUGS
REMINGTON, RD
DRUG THERAPY, 1977, 7 (09) : 59 - 61
[42] POST-MARKETING MONITORING OF DRUGS
LEWIS, JA
CHILVERS, C
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1985, 78 (10) : 874 - 877
[43] Post-marketing surveillance of sertindole
Toumi, M
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2002, 6 : S33 - S35
[44] POST-MARKETING DRUG SURVEILLANCE
WALDEN, RJ
PRICHARD, BNC
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (03) : 191 - 192
[45] Post-marketing strategies for medicines
Breckenridge, A.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (01) : 24 - 25
[46] POST-MARKETING SURVEILLANCE OF DRUGS
HARCUS, AW
WARD, AE
SMITH, DW
BRITISH MEDICAL JOURNAL, 1979, 2 (6194): : 867 - 867
[47] Predictive value of the efficacy of glaucoma medications in regulatory trials: Phase I-III to post-marketing studies
Stewart, W. C.
Jenkins, J. N.
EYE, 2008, 22 (08) : 985 - 988
[48] A PRESCRIPTION FOR POST-MARKETING SURVEILLANCE
ROUTMAN, KD
DRUG & COSMETIC INDUSTRY, 1980, 126 (06): : 60 - 64
[49] POST-MARKETING SURVEILLACE OF THE RETINOIDS
Diane ChenHead Drug Safety F HoffmannLa Roche CoPostfach CH Basel
中国临床药理学杂志, 1988, (04) : 222 - 227
[50] Post-Marketing Safety-Related Regulatory Actions of Same Class Drugs
Stefansdottir, Gudrun
De Bruin, Marie L.
Knol, Mirjam J.
Grobbee, Diederick E.
Leufkens, Hubert G. M.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S224 - S225

← 1 2 3 4 5 →